Interventional study to find out effect of human chorionic gonadotropin and antioxidants on idiopathic male infertility

Authors

  • Namrata V. Padvi Department of Reproductive Medicine and infertility, Nadkarni’s 21st Century Hospital and Test Tube Baby Centre, Surat, Gujrat, India
  • Pooja P. Singh Department of Reproductive Medicine and infertility, Nadkarni’s 21st Century Hospital and Test Tube Baby Centre, Surat, Gujrat, India
  • Kishore M. Nadkarni Department of Andrology and Sexology, Nadkarni’s 21st Century Hospital and Test Tube Baby Centre, Surat, Gujrat, India
  • Prabhakar M. Singh Department of Clinical Embryology and Andrology, Nadkarni’s 21st Century Hospital and Test Tube Baby Centre, Surat, Gujrat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20170369

Keywords:

ART, ICSI, Male infertility, Sperm

Abstract

Background: Male contributes about 50% for cases with combined male and female infertility. When the cause is not known, it is term as idiopathic infertility. It affects 25% of men. Many advances have been made in reproductive medicine which provides great opportunities, couples which were considered untreatable now have got chance to have their own babies. Various ART procedures like ICSI have been proven as an efficient therapy in severe male factor infertility. However, the cost per cycle and complications such as multiple gestations cannot be ignored. Medical management of infertility can be specific or empirical depending on etiology. Specific medical management is use when certain etiology is identified. However, in absence of specific etiology use of empirical medical treatment can be attempted in order to improve treatment results. In this study our aim is to evaluate the effect of human chorionic gonadotropin (hCG) and antioxidants on semen parameters in men with idiopathic male infertility.

Methods: Thirty men with abnormal semen parameters were included in study. Patients were treated with injection hCG-2000 IU three times a week for three months along with the antioxidants. After 3 months of treatment repeat semen analysis were performed and results were compared with pre-treated seminal parameters.

Results: Results showed significant increase in sperm count (p value ≤ 0.001), total motility (p value=<0.001), and progressive forward motility (p value = <0.001), while no significant difference is seen in rest of the parameters.

Conclusions: Use of hCG and antioxidants in idiopathic male infertility can significantly improve seminal parameters in idiopathic male infertility.

Metrics

Metrics Loading ...

References

World Health Organization. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press; 2000.

Jung JH, Seo JT. Empirical medical therapy in idiopathic male infertility: Promise or panacea? Clin Exp Reprod Med. 2014;41(3):108-14.

Meacham RB, Lipshultz LI, Howards SS. Male infertility. In: Gillenwater JY, Grayhack JT, Howards SS, Duckett JW, eds. Adult and pediatric urology. St Louis: Mosby-Year Book; 1996:1747-802.

Cocuzza M, Agarwal A. Nonsurgical treatment of male infertility: specific and empiric therapy. Biologics: Targets and Therapy. 2007;1(3):259-69.

Gudeloglu A, Brahmbhatt JV, Parekattil SJ. Medical management of male infertility in the absence of a specific etiology. Semin Reprod Med. 2014;32(4):313-8.

Cooper TG, Noonan E, von Eckardstein S. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16(3):231.

Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the sub fertile male. Fertil Steril. 1979;31(6):666-8.

Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clin. 2013;68(Suppl 1):81-8.

Jennifer A, Mark S, Charles J, Allan M, David J. Luteinizing hormone receptor mediated effects on initiation of spermatogenesis in gonadotropin deficient mice. Biol Reproduct. 2004;70:32-8.

AACE Hypogonadism Task Force. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients, 2002 update. Endocrine Practice. 2002;8(6):439-456.

MacLeod J. The role of oxygen in the metabolism and motility of human spermatozoa. Ame J Physiol. 1943;138:512-8.

Ko EY, Sabanegh ES, Agarwal A. Male infertility testing: reactive oxygen species and antioxidant capacity. Fertil Steril. 2014;102(6):1518-27.

Garg H, Kumar R. Empirical drug therapy for idiopathic male infertility: what is the new evidence? Urol. 2015;86(6):1065-75.

Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2011:CD007411.

Downloads

Published

2017-01-31

How to Cite

Padvi, N. V., Singh, P. P., Nadkarni, K. M., & Singh, P. M. (2017). Interventional study to find out effect of human chorionic gonadotropin and antioxidants on idiopathic male infertility. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6(2), 496–499. https://doi.org/10.18203/2320-1770.ijrcog20170369

Issue

Section

Original Research Articles